ALAR PHARMACEUTICALS INC.
Update：2026/01/07
Industries
Main Industry
Biotechnology
Main Product/Service
Different from the current long-acting technologies, drug products developed by our unique long-acting release platform (In-Relar) have distinctive characteristics such as low viscosity solution, small injection volume, and sustained drug release profile,
Founded Year
2016
Unified Business No.
52310651
Status
Active
Number of Employees
0
Total Paid-in
Capital
668,000,000 (NT$)
Location of Company
Taiwan
, Taichung City
Exit Status
OTC listing(2025)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Alar Pharmaceuticals Inc., established in 2016, is a new drug development company focusing on developing long-acting release drug products for CNS disorders and chronic diseases. Aiming to submit the new drug application via the 505(b)(2) regulatory pathw
